Symptom Relief and Quality of Dying and Death (QODD) in Patients with Interstitial Lung Disease and Lung Cancer: A Multicenter Cross-sectional Study - Symptom Relief and Quality of Dying and Death (QODD) in Patients with Interstitial Lung Disease and Lung Cancer: A Multicenter Cross-sectional Study

Hamamatsu university school of medicine0 个研究点目标入组 638 人开始时间: 2021年9月22日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•Patients who meet any of the following criteria will not be included in this study 1. Death due to adverse events or judged as treatment-related death. 2. The bereaved family (key person, underwriter) cannot be identified. 3. It is considered difficult for the bereaved family to answer questions about the care they received at the end of life due to restricted visitation. 4. The bereaved family is unable to fill out the survey form due to dementia, mental disability, or visual impairment at the time of discharge. 5. Based on the circumstances at the time of discharge and at present, the bereaved family member is mentally unstable, making it undesirable to conduct the study. 6. Implementation of the research is undesirable as a comprehensive judgment by doctors, nurses, and other multidisciplinary professionals due to strong distrust or misunderstanding of the medical care received or extremely poor relationships with medical personnel.

发起方